Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2002 | 05-2002 | 02-2002 | 11-2001 | 08-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,800 | -2,620 | 17,250 | 25,650 | 12,060 |
| Depreciation Amortization | 12,580 | 6,650 | 29,040 | 21,250 | 14,030 |
| Other Working Capital | 580 | 26,930 | 38,730 | -12,230 | -51,610 |
| Other Operating Activity | 980 | 120 | 6,120 | 5,190 | 6,340 |
| Operating Cash Flow | $21,940 | $31,080 | $91,140 | $39,860 | $-19,180 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,370 | -4,300 | -44,260 | -39,960 | -29,060 |
| Net Acquisitions | 0 | 0 | -55,280 | -55,280 | -55,280 |
| Other Investing Activity | 0 | 0 | -100 | 0 | 0 |
| Investing Cash Flow | $-12,370 | $-4,300 | $-99,640 | $-95,240 | $-84,340 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,410 | 1,460 | 17,630 | 47,110 | 68,030 |
| Financing Cash Flow | $1,410 | $1,460 | $17,630 | $47,110 | $68,030 |
| Beginning Cash Position | 45,810 | 45,810 | 36,670 | 36,670 | 36,670 |
| End Cash Position | 56,790 | 74,060 | 45,810 | 28,400 | 1,170 |
| Net Cash Flow | $10,980 | $28,240 | $9,140 | $-8,260 | $-35,490 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,940 | 31,080 | 91,140 | 39,860 | -19,180 |
| Free Cash Flow | 21,940 | 31,080 | 91,140 | 39,860 | -19,180 |